Probiotics Improve Cognitive Impairment by Decreasing Bacteria-Related Pattern Recognition Receptor-Mediated

Xue-Qin Yang1, Yang Zhao1, Li Xue2

  • 1Department of Pharmacy, Guangyuan Central Hospital, Affiliated Hospital of North Sichuan Medical College, 628000 Guangyuan, Sichuan, China.

Abstract

Insights

Probiotics improved cognitive impairment in mice by reducing gut-brain axis inflammation. This therapeutic potential involves inhibiting the caspase-11/caspase-1 pathway and decreasing alpha-kinase 1 expression.

Area of Science:

  • Neuroscience
  • Microbiology
  • Immunology

Background:

  • Emerging research suggests probiotics may alleviate cognitive impairment in Alzheimer's disease.
  • Previous studies linked probiotics to improved cognition via Toll-like receptor 4 and retinoic-acid-inducible gene-I pathways.
  • The impact of probiotics on other bacterial pattern recognition receptors remains largely unexplored.

Purpose of the Study:

  • To investigate the effects of probiotics on cognitive impairment in senescence-accelerated mice.
  • To elucidate the molecular mechanisms underlying probiotic-mediated improvements in cognitive function.
  • To explore probiotic interactions with various bacteria-related pattern recognition receptors.

Main Methods:

  • Senescence-accelerated mouse prone 8 (SAMP8) mice were administered ProBiotic-4 (a mix of four bacterial strains) orally for 12 weeks.
  • Cognitive function, synaptic integrity, neuronal injury, and microglial activation were assessed.
  • Expression levels of intestinal tight junction proteins, inflammatory cytokines (interleukin-1β), and key signaling molecules (caspase-11, caspase-1, and α-kinase 1) were analyzed.

Main Results:

  • ProBiotic-4 treatment significantly improved memory deficits and reduced neuronal damage and microglial activation in SAMP8 mice.
  • Probiotic administration enhanced intestinal barrier function by increasing tight junction protein expression.
  • Key inflammatory markers, including interleukin-1β, caspase-11, cleaved caspase-1, and α-kinase 1 (ALPK1), were significantly downregulated in both the intestine and brain.

Conclusions:

  • Probiotics demonstrate therapeutic potential for managing gut-brain axis inflammation and cognitive impairment.
  • The observed benefits are associated with the inhibition of the caspase-11/caspase-1 signaling pathway.
  • Probiotic-induced reduction in ALPK1 expression is a key mechanism contributing to cognitive improvement.